Decibel Therapeutics Stock
A clinical-stage biotechnology company focused on developing treatments to restore functional hair cells in the inner ear, addressing hearing and balance disorders. Its platform combines single-cell genomics, bioinformatics, precision gene therapy, and expertise in inner ear biology.
Founded: 2015
For more Decibel Therapeutics stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Charles Liberman, PhD Co-Founder |
| Gabriel Corfas, PhD Co-Founder |
| Albert Edge, PhD Co-Founder |
| Ulrich Muller, PhD Co-Founder |
| Peter Weber, MD Chief Medical Officer |
| Paula Cobb Chief Operating Officer |
